nicotine has been researched along with Carcinoma, Squamous Cell of Head and Neck in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Hsueh, CY; Huang, Q; Ji, M; Shen, Y; Zhou, L | 1 |
Eguchi, T; Ibaragi, S; Kawai, H; Kodama, S; Kuwajima, D; Nagatsuka, H; Nishioka, T; Obata, K; Okamoto, K; Okui, T; Ono, K; Sasaki, A; Shimizu, R; Takabatake, K | 1 |
2 other study(ies) available for nicotine and Carcinoma, Squamous Cell of Head and Neck
Article | Year |
---|---|
Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas.
Topics: Head and Neck Neoplasms; Humans; Nicotine; Prognosis; Receptors, Nicotinic; Smoking; Squamous Cell Carcinoma of Head and Neck | 2022 |
Nicotine promotes lymph node metastasis and cetuximab resistance in head and neck squamous cell carcinoma.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Proliferation; Cell Survival; Cetuximab; Drug Resistance, Neoplasm; ErbB Receptors; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Mice; Nicotine; Phosphorylation; Protein Transport; Proto-Oncogene Proteins c-akt; Receptors, Nicotinic; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; TOR Serine-Threonine Kinases | 2019 |